Cargando…
In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure
New heart failure therapies that safely augment cardiac contractility and output are needed. Previous apelin peptide studies have highlighted the potential for APJ (apelin receptor) agonism to enhance cardiac function in heart failure. However, apelin’s short half-life limits its therapeutic utility...
Autores principales: | Gargalovic, Peter, Wong, Pancras, Onorato, Joelle, Finlay, Heather, Wang, Tao, Yan, Mujing, Crain, Earl, St-Onge, Stéphane, Héroux, Madeleine, Bouvier, Michel, Xu, Carrie, Chen, Xue-Qing, Generaux, Claudia, Lawrence, Michael, Wexler, Ruth, Gordon, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982131/ https://www.ncbi.nlm.nih.gov/pubmed/33663236 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007351 |
Ejemplares similares
-
The Apelin/APJ System in Psychosis and Neuropathy
por: Lv, Shuang-Yu, et al.
Publicado: (2020) -
The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015) -
Expanding role for the apelin/APJ system in physiopathology
por: Carpéné, C., et al.
Publicado: (2007) -
The Role of Apelin–APJ System in Diabetes and Obesity
por: Li, Cheng, et al.
Publicado: (2022) -
The Role of the Apelin/APJ System in the Regulation of Liver Disease
por: Lv, Xinrui, et al.
Publicado: (2017)